07.29.25 -- A Flexible Mindset For Bridging Between Cell-Based Assay Groups

Optimize your biopharmaceutical technology transfer by prioritizing clear communication, thorough training, and strategic planning to ensure success.

Leverage this hybridoma discovery and humanization platform to develop high-affinity, cross-reactive monoclonal antibodies against Type I transmembrane protein targets.

Explore how our contract manufacturing solutions can help you meet the growing demand for seasonal influenza vaccines efficiently and effectively.

Enhance RNA manufacturing with HiCap T7 RNA Polymerase, which minimizes dsRNA, boosts expression, and reduces capping costs for superior therapeutic development.

Using a contract or toll manufacturer in the specialty and custom chemical industry can be viewed as a quality and supply chain risk. Learn what equipment sourcing strategies can mitigate those risks.